Skip to main content
OpenTrials

Clinical trial condition

Hemophilia B

Explore clinical trials studying Hemophilia B. Study availability and eligibility vary by location and protocol.

126 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia B trial results

Completed

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)

NCT04731701

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Swedish Orphan Biovitrum Clinical site Paris, Cochin, France
  • Swedish Orphan Biovitrum Clinical site Paris, Kremlin-Bicêtre, France
  • Swedish Orphan Biovitrum Clinical site Besançon, France
  • Swedish Orphan Biovitrum Clinical site Bordeaux, France
View all 16 locations
View Trial Details
Completed

RIXUBIS Drug Use-Result Survey (Japan)

NCT02937831

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Seki-shi, Japan Seki-shi, Gifu, Japan
  • Maebashi-shi, Japan Maebashi, Gunma, Japan
  • Nobeoka-shi, Japan Nobeoka-shi, Miyazaki, Japan
  • Niigata-shi, Japan Niigata, Japan
View Trial Details
Completed

Dose Confirmation Trial of AAV5-hFIXco-Padua

NCT03489291

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • University of California, Davis Sacramento, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Completed

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

NCT02554773

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Clinical Trial Site Ann Arbor, Michigan, United States
  • Clinical Trial Site Pittsburgh, Pennsylvania, United States
  • Clinical Trial Site Plovdiv, Bulgaria
  • Clinical Trial Site Sofia, Bulgaria
View Trial Details
Completed

Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B

NCT03855280

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Centro Estadual de Hemopterapia e Hematologia do Espirito Santo Vitória, Espírito Santo, Brazil
  • Universidade Estadual de Campinas - Centro de Hematologia e Hemoterapia Campinas, Brazil
  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo Ribeirão Preto, Brazil
  • JSC K Eristavi National Center for Experimental and Clinical Surgery Tbilisi, Georgia
View Trial Details
Completed

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia

NCT05804734

Conditions
Anticoagulant-induced Bleeding, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +9 more
Locations
  • Hemophilia treatment center of Brest Brest, France
  • Hemophilia treatment center of caen Caen, France
  • Hemophilia treatment center of Le Mans Le Mans, France
  • Hemophilia treatment center of Nantes Nantes, France
View Trial Details
Completed

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

NCT03818529

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +14 more
Locations
  • Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital Phoenix, Arizona, United States
  • Valley Children's Hospital Madera, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • UCSF Pediatric Hemophilia Treatment Center at Mission Bay San Francisco, California, United States
View all 27 locations
View Trial Details
Completed

AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)

NCT04272554

Conditions
Blood Coagulation Disorder, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +9 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of California - Davis Sacramento, California, United States
  • University of South Florida Tampa, Florida, United States
View all 56 locations
View Trial Details
Completed

RIXUBIS PMS India (RIXUBIS PMS)

NCT03565237

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Sahyadri Super Speciality Hospital Pune, Maharashtra, India
View Trial Details

Related conditions